Evaluation of mid-regional pro-atrial natriuretic peptide,procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients |
| |
Authors: | Orhan Cinar Erdem Cevik Ayhan Acar Cengiz Kaya Sukru Ardic Bilgin Comert Mehmet Yokusoglu Cumhur Bilgi Michael Meisner Troy Madsen |
| |
Institution: | 1. Department of Emergency Medicine, Gulhane Military Medical Academy, GATA Acil Tip Anabilim Dal?, Etlik, Ankara, Turkey 06010;2. Department of Cardiology, Gulhane Military Medical Academy, GATA Kardiyoloji Anabilim Dal?, Etlik, Ankara, Turkey 06010;3. Department of Medical Biochemistry, Gulhane Military Medical Academy, GATA Biyokimya Anabilim Dal?, Etlik, Ankara, Turkey 06010;4. Dresden, Germany, D-01129 Dresden, Industriestr. 40;5. Division of Emergency Medicine, University of Utah, 30 N. 1900 E. 1C26, Salt Lake City, UT 84132 |
| |
Abstract: | ObjectiveThe aim of this study was to evaluate the diagnostic and the prognostic value of a laboratory panel consisting of mid-regional pro-atrial natriuretic peptide (MR-proANP), procalcitonin (PCT), and mid-regional pro-adrenomedullin (MR-proADM) for patients presenting to the emergency department (ED) with acute dyspnea.MethodsWe prospectively enrolled ED patients who presented with a chief complaint of dyspnea and who had an uncertain diagnosis after physician evaluation. Final primary diagnosis of the cause of shortness of breath was confirmed through additional testing per physician discretion. We recorded inpatient admission and 30-day mortality rates.ResultsOne hundred fifty-four patients were enrolled in the study. Congestive heart failure exacerbation was the final primary diagnosis in 42.2% of patients, while infectious etiology was diagnosed in 33.1% of patients. For the diagnosis of congestive heart failure exacerbation, MR-proANP had a sensitivity of 92.7% and specificity of 36.8%, with a negative likelihood ratio (LR−) of 0.16 and a positive likelihood ratio (LR+) of 1.44 (cut-off value: 120 pmol/L). For the diagnosis of an infectious etiology, PCT had a 96.5% specificity and 48.8% sensitivity (LR−: 0.58, LR+: 13.8, cutoff value: 0.25 ng/mL). As a prognostic indicator, MR-proADM demonstrated similar values: odds ratio for 30-day mortality was 8.5 (95% CI, 2.5-28.5, cutoff value: 1.5 nmol/L) and the area under the receiver operating characteristic curve in predicting mortality was 0.81 (95% CI, 0.71-0.91).ConclusionThe good negative LR− of MR-proANP and the good positive LR+ of PCT may suggest a role for these markers in the early diagnosis of ED patients with dyspnea. Furthermore, MR-proADM may assist in risk stratification and prognosis in these patients.. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|